Wed Jan 01 2025
cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.
Drug | Manufacturer | Distribution Pattern | Number of Affected Units |
---|---|---|---|
UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323 | Product was sold via Amazon Marketplace. | 321 bottles |